THBD and cancer: Although high expression of thrombomodulin has been reported by multiple groups in diverse cancer indications, whether thrombomodulin can actually elicit an immunosuppressive function in the context of cancer remains to be elucidated and the finding that low thrombomodulin leads to improved prognosis seems to contradict this theory.